Wuhan Keqian Biology Co Ltd Class A 688526
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥11.70
- Day Range
- CN¥11.47–11.80
- 52-Week Range
- CN¥11.11–17.81
- Bid/Ask
- CN¥11.62 / CN¥11.64
- Shares Outstanding
- 466.13M
- Market Cap
- CN¥5.43B
- Volume/Avg
- 1M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 24.43
- Price/Sales
- 6.91
- Dividend Yield (Trailing)
- 5.50%
- Dividend Yield (Forward)
- 5.50%
- Dividend Payment Schedule
- May
- Total Yield
- 5.50%
Company Profile
Wuhan Keqian Biology Co Ltd is engaged in Research and development, production, and sales of veterinary biological products, as well as animal disease prevention and control technical services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 950
- Website
- http://www.kqbio.com
Valuation
Metric | 688526 |
|---|---|
Price/Earnings (Normalized) | 24.43 |
Price/Book Value | 1.33 |
Price/Sales | 6.91 |
Price/Cash Flow | 14.34 |
Price/Earnings
688526
Financial Strength
Metric | 688526 |
|---|---|
Quick Ratio | 5.10 |
Current Ratio | 7.80 |
Interest Coverage | — |
Quick Ratio
688526
Profitability
Metric | 688526 |
|---|---|
Return on Assets (Normalized) | 4.24% |
Return on Equity (Normalized) | 4.78% |
Return on Invested Capital (Normalized) | 3.92% |
Return on Assets
688526
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|<wQGh%K | LOCK|y%x# | $139B | |||
| Moderna Inc MRNA | LOCK|Z@mKp&N | LOCK|?@ | $103B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|fx?x!Gt | LOCK|zP^LV | $94B | |||
| argenx SE ADR ARGX | LOCK|zGs?#># | LOCK|$@ | $58B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|s>Bg^x | LOCK|zN | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|GZd!n$N | LOCK|dfj# | $30B | |||
| Incyte Corp INCY | LOCK|>g@!D^x | LOCK|w^ | $24B | |||
| BioNTech SE ADR BNTX | LOCK|YFdxS@ | LOCK|h# | $22B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|$jKCY^k | LOCK|b$$$j | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|pQsMz&& | LOCK|kJ@ | $15B |
United States